The global in-vitro fertilisation (IVF) market is experiencing consistent and transformational growth, driven by rising infertility rates, societal trends, and technological advancements. The demand for IVF procedures is growing due to increased awareness of fertility treatments and support from governments and healthcare insurers. The United Kingdom, along with other European countries, is a significant market for IVF, with government reimbursement schemes and rising investments in reproductive research. IVF clinics are becoming more prevalent, and the integration of new technologies such as artificial intelligence and preimplantation genetic testing is expected to further propel the market. However, challenges such as high costs, limited insurance coverage, and ethical concerns persist.